22/04/2026
According to an independent study*, radiodermatitis affects 94% of breast cancer patients during radiotherapy. Make a difference by recommending Flamigel® RT from day 1 of treatment and help reduce the incidence of skin reactions, ensuring better care for your patients.
*Censabella S et al., Efficacy of a hydroactive colloid gel versus historical controls for the prevention of radiotherapy induced moist desquamation in breast cancer patients. Eur J Oncol Nurs. 2017;29:1-7.
Flamigel® RT is a hydro-active colloid gel for the symptomatic treatment of low grade radiotherapy-induced skin reactions.